StemCells plans chronic spinal cord injury trial
Monday, November 15, 2010 - 08:01
in Health & Medicine
LOS ANGELES (Reuters) - StemCells Inc has filed for Swiss regulatory approval for the first clinical trial of its nerve stem cells in patients with spinal cord injuries as much as a year old, the company said.